Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Fussenegger

Showing results (111-120 of 330) with videos related to

Pageof 33
Sort By:
Journal of Biotechnology|January 2, 2007
A novel generic dipstick-based technology for rapid and precise detection of tetracycline, streptogramin and macrolide antibiotics in food samplesNils Link, Wilfried Weber, Martin Fussenegger
Metabolic Engineering|July 5, 2011
Smart medication through combination of synthetic biology and cell microencapsulationSimon Ausländer, Markus Wieland, Martin Fussenegger
Plos One|August 15, 2009
Epigenetic engineering of ribosomal RNA genes enhances protein productionRaffaella Santoro, Philipp Lienemann, Martin Fussenegger
Nature Biomedical Engineering|April 24, 2019
Synthetic gene circuits for the detection, elimination and prevention of diseaseFerdinand Sedlmayer, Dominique Aubel, Martin Fussenegger
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2011
Design and construction of synthetic gene networks in mammalian cellsMaria Karlsson, Wilfried Weber, Martin Fussenegger
Methods (San Diego, Calif.)|February 7, 2012
Engineering of ribozyme-based riboswitches for mammalian cellsMarkus Wieland, David Ausländer, Martin Fussenegger
Current Opinion in Biotechnology|March 11, 2019
Genetic circuitry for personalized human cell therapyFabian Tolle, Pascal Stücheli, Martin Fussenegger
Journal of Biotechnology|October 6, 2012
Genetically programmed superparamagnetic behavior of mammalian cellsTaeuk Kim, David Moore, Martin Fussenegger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 12, 2021
Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene TherapyHanna J Wagner, Wilfried Weber, Martin Fussenegger
Investigational New Drugs|May 4, 2004
A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cellsValeria Gonzalez-Nicolini, Cornelia Fux, Martin Fussenegger
Pageof 33

Showing results (111-120 of 330) with videos related to

Sort By:
Pageof 33
Journal of Biotechnology|January 2, 2007
A novel generic dipstick-based technology for rapid and precise detection of tetracycline, streptogramin and macrolide antibiotics in food samplesNils Link, Wilfried Weber, Martin Fussenegger
Metabolic Engineering|July 5, 2011
Smart medication through combination of synthetic biology and cell microencapsulationSimon Ausländer, Markus Wieland, Martin Fussenegger
Plos One|August 15, 2009
Epigenetic engineering of ribosomal RNA genes enhances protein productionRaffaella Santoro, Philipp Lienemann, Martin Fussenegger
Nature Biomedical Engineering|April 24, 2019
Synthetic gene circuits for the detection, elimination and prevention of diseaseFerdinand Sedlmayer, Dominique Aubel, Martin Fussenegger
Methods in Molecular Biology (Clifton, N.J.)|November 16, 2011
Design and construction of synthetic gene networks in mammalian cellsMaria Karlsson, Wilfried Weber, Martin Fussenegger
Methods (San Diego, Calif.)|February 7, 2012
Engineering of ribozyme-based riboswitches for mammalian cellsMarkus Wieland, David Ausländer, Martin Fussenegger
Current Opinion in Biotechnology|March 11, 2019
Genetic circuitry for personalized human cell therapyFabian Tolle, Pascal Stücheli, Martin Fussenegger
Journal of Biotechnology|October 6, 2012
Genetically programmed superparamagnetic behavior of mammalian cellsTaeuk Kim, David Moore, Martin Fussenegger
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 12, 2021
Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene TherapyHanna J Wagner, Wilfried Weber, Martin Fussenegger
Investigational New Drugs|May 4, 2004
A novel mammalian cell-based approach for the discovery of anticancer drugs with reduced cytotoxicity on non-dividing cellsValeria Gonzalez-Nicolini, Cornelia Fux, Martin Fussenegger
Pageof 33